The Jharkhand High Court has rejected the plea of Aventis Pharma, a global healthcare company, seeking to dismiss the entire criminal proceedings related to a complaint filed under section 27 of the Drug and Cosmetics Act, 1940. Placing reliance on the Apex Court's judgement in Glaxosmithkline Pharmaceuticals Limited and Another Vs. State of Madhya Pradesh, he emphasized, “As discussed hereinabove, …
Recent data from the Central Drugs Standard Control Organisation, shows that at least 6% of cough syrup samples from 54 Indian manufacturers failed a mandatory quality test for export. Screening of medicines bound for the export market began earlier this year after quality concerns were raised about cough syrups manufactured in India for export. According to government data, of the …
The Central Drugs Standard Control Organisation has instructed Tamil Nadu-based Global Pharma Healthcare to stop manufacturing all the products under the category of ophthalmic preparation till the completion of an investigation. The move came soon after the U.S. Centers for Disease Control and Prevention linked the company’s eye drops to 55 adverse events in the U.S. On Friday, a joint …
Prescription drugs used to treat type-2 diabetes and over-the-counter painkiller manufactured by Maiden Pharmaceuticals Ltd, a Delhi-based company having its manufacturing unit at Kundli in Sonepat district of Haryana, were found to be substandard during lab tests in Kerala on at least five occasions during the past nine months. Samples that failed as early as June and Sept 2022 As …
